Page last updated: 2024-08-25

doripenem and Cholangitis

doripenem has been researched along with Cholangitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Igarashi, Y; Inui, K; Ohara, H; Ryozawa, S; Tazuma, S; Tsuyuguchi, T	1
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K	1
Kato, K; Nishikawa, T; Sakai, Y; Sugiyama, H; Takahashi, M; Tsuyuguchi, T; Yokosuka, O	1

Trials

1 trial(s) available for doripenem and Cholangitis

Article	Year
Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator. Journal of gastroenterology, 2015, Volume: 50, Issue:2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult	2015

Article

Year

Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.

Journal of gastroenterology, 2015, Volume: 50, Issue:2

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult

2015

Other Studies

2 other study(ies) available for doripenem and Cholangitis

Article	Year
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis. Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2 Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam	2017
Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study. International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:1 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Cholangitis; Doripenem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2013

Article

Year

Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.

Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2

Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam

2017

Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study.

International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:1

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Cholangitis; Doripenem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2013